Stay updated on Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.

Latest updates to the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor site release without any change to the underlying study details.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2. This appears to be a minor backend/UI update with no impact on the study content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision note updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page shows a new revision note (v3.4.2). A funding/status notice and the earlier revision (v3.4.1) have been removed.SummaryDifference0.4%

- Check85 days agoChange DetectedA site-wide status notice about potential delays in updates due to government funding and the NIH Clinical Center's operating status was added, and a new revision tag (v3.4.1) was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.